Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03329950
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2017-10-23
Brief Title:
A Study of CDX-1140 CD40 as Monotherapy or in Combination in Patients With Advanced Malignancies
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics
Organization Data
Organization:
Celldex Therapeutics
Class:
INDUSTRY
Study ID:
CDX1140-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celldex Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |